Cargando…
Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury
INTRODCUTION: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are major causes of COVID-19 mortality. However, drug delivery to lung tissues is impeded by endothelial cell barriers, limiting the efficacy of existing treatments. A prompt and aggressive treatment strategy is the...
Autores principales: | Zhao, Yue, Jin, Hua, Lei, Kawai, Bai, Li-Ping, Pan, Hudan, Wang, Caiyan, Zhu, Xiaoming, Tang, Yanqing, Guo, Zhengyang, Cai, Jiye, Li, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116055/ https://www.ncbi.nlm.nih.gov/pubmed/37090710 http://dx.doi.org/10.3389/fimmu.2023.1163397 |
Ejemplares similares
-
Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017) -
Influence of verapamil on the pharmacokinetics of oridonin in rats
por: Liu, Jing, et al.
Publicado: (2019) -
Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis
por: Zhang, Zhi-Yuan, et al.
Publicado: (2013) -
Preliminary safety assessment of oridonin in zebrafish
por: Tian, Lili, et al.
Publicado: (2019) -
Oridonin Attenuates Lipopolysaccharide-Induced ROS Accumulation and Inflammation in HK-2 Cells
por: Huang, Jen-Hsuan, et al.
Publicado: (2020)